Oxford Cancer Biomarkers

Oxford Biomarkers

This company develops AI-driven precision diagnostic tests and biomarkers to help clinicians personalise cancer treatments and identify chemotherapy toxicity risks for patients.

Delphi Diagnostics

This company develops genomic tests for breast cancer to assist clinicians and patients in personalising treatment decisions and predicting long-term survival outcomes.

Oncomark

This company develops prognostic tests for breast cancer patients to help clinicians determine the necessity of chemotherapy treatment.

Celleron Therapeutics

This biopharmaceutical company develops precision medicine drugs and companion diagnostics for cancer patients to provide personalised oncology treatments.

Oncobit

This company develops precision diagnostic assays and cloud-based monitoring software for clinicians to track cancer markers and therapy response in oncology patients.

Persona-Dx

The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.

Precision for Medicine

This company provides biomarker-driven clinical research and development services for pharmaceutical and biotechnology organisations to accelerate the commercialisation of personalised medicines.

Cambridge Cancer Genomics

This company develops precision oncology software for clinicians to monitor treatment response and detect cancer relapse using genomic data and blood samples.